NO306561B1 - Dyrkingsmedium for krevende organismer - Google Patents

Dyrkingsmedium for krevende organismer Download PDF

Info

Publication number: NO306561B1
Authority: NO; Norway
Prior art keywords: culture medium; nad; fos; hemin; blood
Prior art date: 1990-12-06

Application number

NO914764A

Other languages

English (en)

Norwegian (no)

Other versions

NO914764L (no

NO914764D0 (no

Inventor

Paul E Goldenbaum

Ann M Graziosi

Original Assignee

Becton Dickinson Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-06

Filing date

1991-12-04

Publication date

1999-11-22

1991-12-04 Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co

1991-12-04 Publication of NO914764D0 publication Critical patent/NO914764D0/no

1992-06-09 Publication of NO914764L publication Critical patent/NO914764L/no

1999-11-22 Publication of NO306561B1 publication Critical patent/NO306561B1/no

Links

239000001963 growth medium Substances 0.000 title claims abstract description 57
239000003146 anticoagulant agent Substances 0.000 claims abstract description 34
229940127219 anticoagulant drug Drugs 0.000 claims abstract description 34
231100000419 toxicity Toxicity 0.000 claims abstract description 6
230000001988 toxicity Effects 0.000 claims abstract description 6
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 25
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 24
150000001875 compounds Chemical class 0.000 claims description 18
BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 claims description 14
229940025294 hemin Drugs 0.000 claims description 13
239000002609 medium Substances 0.000 claims description 12
108091003079 Bovine Serum Albumin Proteins 0.000 claims description 10
102000001554 Hemoglobins Human genes 0.000 claims description 10
108010054147 Hemoglobins Proteins 0.000 claims description 10
108010010803 Gelatin Proteins 0.000 claims description 9
229920000159 gelatin Polymers 0.000 claims description 9
239000008273 gelatin Substances 0.000 claims description 9
235000019322 gelatine Nutrition 0.000 claims description 9
235000011852 gelatine desserts Nutrition 0.000 claims description 9
229940098773 bovine serum albumin Drugs 0.000 claims description 8
102000004169 proteins and genes Human genes 0.000 claims description 8
108090000623 proteins and genes Proteins 0.000 claims description 8
102000009027 Albumins Human genes 0.000 claims description 7
108010088751 Albumins Proteins 0.000 claims description 7
239000002253 acid Substances 0.000 claims description 7
239000000126 substance Substances 0.000 claims description 6
229920002851 polycationic polymer Polymers 0.000 claims description 5
150000003839 salts Chemical class 0.000 claims description 5
150000003628 tricarboxylic acids Chemical class 0.000 claims description 4
239000004475 Arginine Substances 0.000 claims description 3
108010044091 Globulins Proteins 0.000 claims description 3
102000006395 Globulins Human genes 0.000 claims description 3
ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 3
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
239000004472 Lysine Substances 0.000 claims description 3
102000007327 Protamines Human genes 0.000 claims description 3
108010007568 Protamines Proteins 0.000 claims description 3
150000001413 amino acids Chemical class 0.000 claims description 3
125000000129 anionic group Chemical group 0.000 claims description 3
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 3
125000002091 cationic group Chemical group 0.000 claims description 3
238000003776 cleavage reaction Methods 0.000 claims description 3
150000002357 guanidines Chemical class 0.000 claims description 3
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 3
229950008679 protamine sulfate Drugs 0.000 claims description 3
230000007017 scission Effects 0.000 claims description 3
BMUDPLZKKRQECS-UHFFFAOYSA-K 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethylporphyrin-21,24-diid-2-yl]propanoic acid iron(3+) hydroxide Chemical compound [OH-].[Fe+3].[N-]1C2=C(C)C(CCC(O)=O)=C1C=C([N-]1)C(CCC(O)=O)=C(C)C1=CC(C(C)=C1C=C)=NC1=CC(C(C)=C1C=C)=NC1=C2 BMUDPLZKKRQECS-UHFFFAOYSA-K 0.000 claims description 2
KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 claims description 2
108010062374 Myoglobin Proteins 0.000 claims description 2
229920006317 cationic polymer Polymers 0.000 claims description 2
229960001231 choline Drugs 0.000 claims description 2
OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 2
150000003278 haem Chemical class 0.000 claims description 2
229940109738 hematin Drugs 0.000 claims description 2
229950003776 protoporphyrin Drugs 0.000 claims description 2
102000036675 Myoglobin Human genes 0.000 claims 1
239000013589 supplement Substances 0.000 abstract description 32
239000003102 growth factor Substances 0.000 abstract description 18
238000001514 detection method Methods 0.000 abstract description 9
238000009640 blood culture Methods 0.000 description 31
229950006238 nadide Drugs 0.000 description 21
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 20
231100000331 toxic Toxicity 0.000 description 15
230000002588 toxic effect Effects 0.000 description 15
210000004369 blood Anatomy 0.000 description 13
239000008280 blood Substances 0.000 description 13
108010014172 Factor V Proteins 0.000 description 12
238000002955 isolation Methods 0.000 description 12
108010014173 Factor X Proteins 0.000 description 11
210000001124 body fluid Anatomy 0.000 description 10
239000010839 body fluid Substances 0.000 description 10
LYPFDBRUNKHDGX-SOGSVHMOSA-N N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 Chemical compound N1C2=CC=C1\C(=C1\C=CC(=N1)\C(=C1\C=C/C(/N1)=C(/C1=N/C(/CC1)=C2/C1=CC(O)=CC=C1)C1=CC(O)=CC=C1)\C1=CC(O)=CC=C1)C1=CC(O)=CC=C1 LYPFDBRUNKHDGX-SOGSVHMOSA-N 0.000 description 9
238000000034 method Methods 0.000 description 9
229960002197 temoporfin Drugs 0.000 description 9
241000606790 Haemophilus Species 0.000 description 8
239000012530 fluid Substances 0.000 description 7
241000588653 Neisseria Species 0.000 description 6
235000018102 proteins Nutrition 0.000 description 6
241000606768 Haemophilus influenzae Species 0.000 description 5
241000588652 Neisseria gonorrhoeae Species 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
210000001175 cerebrospinal fluid Anatomy 0.000 description 5
244000005700 microbiome Species 0.000 description 5
239000000243 solution Substances 0.000 description 5
241000894006 Bacteria Species 0.000 description 4
239000012141 concentrate Substances 0.000 description 4
230000003472 neutralizing effect Effects 0.000 description 4
241000207201 Gardnerella vaginalis Species 0.000 description 3
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical group C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
241000588650 Neisseria meningitidis Species 0.000 description 3
239000007864 aqueous solution Substances 0.000 description 3
229940047650 haemophilus influenzae Drugs 0.000 description 3
239000004615 ingredient Substances 0.000 description 3
238000006386 neutralization reaction Methods 0.000 description 3
230000001175 peptic effect Effects 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
MXXTVDSLIANCNG-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate;dimethyl sulfate;1-ethenylpyrrolidin-2-one Chemical compound COS(=O)(=O)OC.C=CN1CCCC1=O.CN(C)CCOC(=O)C(C)=C MXXTVDSLIANCNG-UHFFFAOYSA-N 0.000 description 2
208000031729 Bacteremia Diseases 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
206010017523 Fungaemia Diseases 0.000 description 2
241000207202 Gardnerella Species 0.000 description 2
241000606766 Haemophilus parainfluenzae Species 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
241000202944 Mycoplasma sp. Species 0.000 description 2
241001494479 Pecora Species 0.000 description 2
241000192035 Peptostreptococcus anaerobius Species 0.000 description 2
108010071390 Serum Albumin Proteins 0.000 description 2
102000007562 Serum Albumin Human genes 0.000 description 2
241001478880 Streptobacillus moniliformis Species 0.000 description 2
239000000654 additive Substances 0.000 description 2
229940024606 amino acid Drugs 0.000 description 2
235000001014 amino acid Nutrition 0.000 description 2
210000003567 ascitic fluid Anatomy 0.000 description 2
235000010633 broth Nutrition 0.000 description 2
229940041514 candida albicans extract Drugs 0.000 description 2
238000012258 culturing Methods 0.000 description 2
150000001991 dicarboxylic acids Chemical class 0.000 description 2
210000003743 erythrocyte Anatomy 0.000 description 2
238000011156 evaluation Methods 0.000 description 2
BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical group [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 description 2
230000002401 inhibitory effect Effects 0.000 description 2
230000005764 inhibitory process Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
238000009629 microbiological culture Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
235000003170 nutritional factors Nutrition 0.000 description 2
238000004806 packaging method and process Methods 0.000 description 2
229940074571 peptostreptococcus anaerobius Drugs 0.000 description 2
229920001463 polyanetholesulfonic acid sodium salt Polymers 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000007787 solid Substances 0.000 description 2
241000894007 species Species 0.000 description 2
KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 2
108010050327 trypticase-soy broth Proteins 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
150000003722 vitamin derivatives Chemical class 0.000 description 2
239000012138 yeast extract Substances 0.000 description 2
QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 1
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
239000004381 Choline salt Substances 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
229930182816 L-glutamine Natural products 0.000 description 1
102100030856 Myoglobin Human genes 0.000 description 1
206010057249 Phagocytosis Diseases 0.000 description 1
LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
241000295644 Staphylococcaceae Species 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
244000299461 Theobroma cacao Species 0.000 description 1
235000009470 Theobroma cacao Nutrition 0.000 description 1
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229940126575 aminoglycoside Drugs 0.000 description 1
229960003121 arginine Drugs 0.000 description 1
235000009697 arginine Nutrition 0.000 description 1
JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
239000010836 blood and blood product Substances 0.000 description 1
208000037815 bloodstream infection Diseases 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
235000019417 choline salt Nutrition 0.000 description 1
-1 co-enzyme A Chemical compound 0.000 description 1
229950001485 cocarboxylase Drugs 0.000 description 1
238000010835 comparative analysis Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000000470 constituent Substances 0.000 description 1
239000013078 crystal Substances 0.000 description 1
229960001305 cysteine hydrochloride Drugs 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
239000001530 fumaric acid Substances 0.000 description 1
229930195712 glutamate Natural products 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
229960002885 histidine Drugs 0.000 description 1
235000014304 histidine Nutrition 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000001802 infusion Methods 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
229960003646 lysine Drugs 0.000 description 1
235000018977 lysine Nutrition 0.000 description 1
235000010335 lysozyme Nutrition 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
229940101270 nicotinamide adenine dinucleotide (nad) Drugs 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
238000012856 packing Methods 0.000 description 1
230000008782 phagocytosis Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
150000003248 quinolines Chemical class 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000001384 succinic acid Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
238000012360 testing method Methods 0.000 description 1
VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
239000001974 tryptic soy broth Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Immunology (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Plant Substances (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Farming Of Fish And Shellfish (AREA)
Mushroom Cultivation (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO914764A 1990-12-06 1991-12-04 Dyrkingsmedium for krevende organismer NO306561B1 (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62287490A	1990-12-06	1990-12-06

Publications (3)

Publication Number	Publication Date
NO914764D0 NO914764D0 (no)	1991-12-04
NO914764L NO914764L (no)	1992-06-09
NO306561B1 true NO306561B1 (no)	1999-11-22

Family

ID=24495852

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO914764A NO306561B1 (no)	1990-12-06	1991-12-04	Dyrkingsmedium for krevende organismer

Country Status (13)

Country	Link
EP (1)	EP0489392B1 (fr)
JP (1)	JP2786962B2 (fr)
AT (1)	ATE148173T1 (fr)
AU (1)	AU653964B2 (fr)
CA (1)	CA2055973C (fr)
DE (1)	DE69124349T2 (fr)
DK (1)	DK0489392T3 (fr)
ES (1)	ES2100199T3 (fr)
FI (1)	FI100990B (fr)
MY (1)	MY106928A (fr)
NO (1)	NO306561B1 (fr)
NZ (1)	NZ240659A (fr)
TW (1)	TW241301B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5494808A (en) *	1994-09-15	1996-02-27	Merck & Co., Inc.	Defined medium OMPC fermentation process
JP3687859B2 (ja) *	1994-10-31	2005-08-24	▲いん▼▲てつ▼ 小林	微生物輸送用培地
US6555333B1 (en) *	2002-05-14	2003-04-29	Pml Microbiologicals, Inc.	Broad spectrum fastidious organism culture medium
US7491517B2 (en) *	2006-07-19	2009-02-17	Jeeri R Reddy	Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
FR2918671B1 (fr)	2007-07-10	2010-10-15	Sanofi Pasteur	Milieu de culture d'haemophilus influenzae type b.
US8389268B2 (en)	2009-07-01	2013-03-05	BIOMéRIEUX, INC.	Method and culture medium for enhanced detection of mycobacterium
US8932851B2 (en)	2009-07-01	2015-01-13	bioMērieux, Inc.	Method and culture medium for enhanced detection of Mycobacterium
CN107043802B (zh)	2009-07-01	2020-11-17	生物梅里埃有限公司	用于分枝杆菌的增强的检测的方法和培养基
US20170022542A1 (en)	2015-07-20	2017-01-26	PZM Diagnostics, LLC	Methods for culture and identification of mycrobacterium avium subspecies in crohn's disease
US20220127657A1 (en) *	2019-03-01	2022-04-28	John Milford AITKEN	A method for detecting dormant or cell wall deficient mycobacterium species and a method and medium for the growth promotion of dormant or cell wall deficient forms of mycobacterium species

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2047739A (en) *	1979-04-27	1980-12-03	Roche Products Ltd	Nutrient medium

1991
- 1991-11-19 NZ NZ240659A patent/NZ240659A/en unknown
- 1991-11-19 AU AU87969/91A patent/AU653964B2/en not_active Ceased
- 1991-11-21 CA CA002055973A patent/CA2055973C/fr not_active Expired - Fee Related
- 1991-11-22 MY MYPI91002159A patent/MY106928A/en unknown
- 1991-11-26 TW TW080109294A patent/TW241301B/zh active
- 1991-12-03 AT AT91120711T patent/ATE148173T1/de not_active IP Right Cessation
- 1991-12-03 DK DK91120711.6T patent/DK0489392T3/da active
- 1991-12-03 ES ES91120711T patent/ES2100199T3/es not_active Expired - Lifetime
- 1991-12-03 DE DE69124349T patent/DE69124349T2/de not_active Expired - Fee Related
- 1991-12-03 EP EP91120711A patent/EP0489392B1/fr not_active Expired - Lifetime
- 1991-12-04 NO NO914764A patent/NO306561B1/no not_active IP Right Cessation
- 1991-12-04 FI FI915713A patent/FI100990B/fi not_active IP Right Cessation
- 1991-12-06 JP JP3323225A patent/JP2786962B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0489392A3 (en)	1992-12-09
ES2100199T3 (es)	1997-06-16
JP2786962B2 (ja)	1998-08-13
AU653964B2 (en)	1994-10-20
EP0489392B1 (fr)	1997-01-22
NO914764L (no)	1992-06-09
MY106928A (en)	1995-08-30
DE69124349D1 (de)	1997-03-06
FI915713A0 (fi)	1991-12-04
CA2055973A1 (fr)	1992-06-07
TW241301B (fr)	1995-02-21
FI915713L (fi)	1992-06-07
NO914764D0 (no)	1991-12-04
AU8796991A (en)	1992-06-11
ATE148173T1 (de)	1997-02-15
NZ240659A (en)	1995-07-26
EP0489392A2 (fr)	1992-06-10
JPH0541975A (ja)	1993-02-23
CA2055973C (fr)	1997-06-10
DK0489392T3 (da)	1997-07-28
FI100990B (fi)	1998-03-31
DE69124349T2 (de)	1997-07-17

Legal Events

Date	Code	Title	Description
2005-09-12	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
Edelstein	1981	Improved semiselective medium for isolation of Legionella pneumophila from contaminated clinical and environmental specimens
Gerhardt	1958	The nutrition of brucellae
JPS60176580A (ja)	1985-09-10	凍結乾燥微生物の培養方法
CA2055973C (fr)	1997-06-10	Supplement d'organisme fastidieux
US6368847B1 (en)	2002-04-09	Selective media for recovery and enumeration of campylobacters
US3671400A (en)	1972-06-20	Bacterial controls and preparation thereof
US4879239A (en)	1989-11-07	Method of culturing freeze-dried microorganisms and resultant preparation
Berman et al.	1918	Bacterial nutrition: Further studies on the utilization of protein and non-protein nitrogen
Minor et al.	1971	Staphylococcus aureus and staphylococcal food intoxications. A review: i. The Staphylococci: characteristics, isolation, and behavior in artificial media
JPH1028599A (ja)	1998-02-03	試料中に存在する微生物細胞に由来するａｔｐを検出及び／または測定する方法、及びその試薬キット
Kramer et al.	1969	Media selective for Listeria monocytogenes
US6037140A (en)	2000-03-14	Selective media for the culture and isolation of gram bacteria, antibiotic composition
Magalhães et al.	2014	Traditional methods for isolation of Listeria monocytogenes
US4728516A (en)	1988-03-01	Method for the preservation of creamed cottage cheese
Hottle et al.	1966	Growth and survival of Mycoplasma neurolyticum in liquid media
Schell et al.	1979	Recovery of Haemophilus influenzae from twenty-three blood culture media
RU2129794C1 (ru)	1999-05-10	Способ получения сухого препарата для производства кисломолочных продуктов
Cyzeska et al.	1981	Culture medium for selective isolation and enumeration of gram-negative bacteria from ground meats
Borghans et al.	1979	Pseudomonas cepacia bacteraemia due to intrinsic contamination of an anaesthetic: bacteriological and serological observations
Brachfeld	1955	Studies on Media Composition and Heat Activation for the Demonstration Ofviability of Spores of Bacillus Stearothermophilus
Smith	1937	The relation of peptone to production of haemolysin by streptococci
Wenzel et al.	1990	Behavior of Listeria monocytogenes in the presence of Streptococcus lactis in a medium with internal pH control
Lawrence	1945	Effects of Enzyme Preparations upon Penicillin: I. A Method for Testing Penicillin for Sterility
Maisi et al.	1984	Mastitis whey—a good medium for bacteria?
SU1337027A1 (ru)	1987-09-15	Способ хранени кефирных грибков